So far, the effects of the dual GIP/GLP-1 receptor agonist, TIR, on markers of neuronal growth (CREB and BDNF levels), apoptosis (BAX/Bcl2 ratio) differentiation, (pAkt, MAP2, GAP43, and AGBL4) and insulin resistance (GLUT1, GLUT4, GLUT3 and SORBS1) in human neuroblastoma cell line (SHSY5Y) exposed to normal (NG) and high concentration of glucose (HG) for 7 days were investigated
Announces Approval And Launch Of Generic GLP-1 Rival To Saxenda By Dave Wallace Stay ahead of every shift in generics and biosimilars
A review of cognitive changes during acute aerobic exercise
is a founder of KoBioLabs Inc., a company that aims to characterize the role of hostmicrobiome interactions in chronic diseases
On the contrary, in developed countries, VAD is linked to pancreatic, liver, and intestinal disorders